Showing results (261-270 of 436) with videos related to
Sort By:
Pageof 44
Frontiers in Molecular Neuroscience|October 18, 2019
Dichloroacetate Stabilizes Mitochondrial Fusion Dynamics in Models of NeurodegenerationDarren O'Hara, Gavin M Davis, Natalie A Adlesic, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 26, 2012
Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009P Zarb, B Amadeo, A Muller, et al.Natural Product Research|March 3, 2025
Acetylcholinesterase and monoamine oxidase inhibitory activities of Pistacia falcata Becc. ex Martelli extractBashaer Alsharif, Matilde Biasiotti, Ammar Bader, et al.Health Technology Assessment (Winchester, England)|September 27, 2005
The causes and effects of socio-demographic exclusions from clinical trialsC Bartlett, L Doyal, S Ebrahim, et al.The Iowa Orthopaedic Journal|June 26, 2024
Improving Applicant Satisfaction in Orthopaedic Surgery Residency Matching: The Role of Preference SignalingLisa M Tamburini, Annabelle P Davey, James C Messina, et al.British Heart Journal|March 1, 1994
QT interval dispersion in chronic heart failure and left ventricular hypertrophy: relation to autonomic nervous system and Holter tape abnormalitiesP P Davey, J Bateman, I P Mulligan, et al.Health Bulletin|June 19, 2003
Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in TaysideD Nathwani, J Morrison, R A Seaton, et al.Irish Journal of Medical Science|February 1, 2011
The value of axillary ultrasound with fine needle aspiration as a pre-operative staging procedure in breast cancer: Northern Irish experienceP Davey, M Stokes, R Kennedy, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 23, 2011
Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in miceHolly L Rosenzweig, Jenna S Clowers, Gabriel Nunez, et al.Molecular Neurodegeneration|July 28, 2011
High-level inhibition of mitochondrial complexes III and IV is required to increase glutamate release from the nerve terminalSeán M Kilbride, Sonia A Gluchowska, Jayne E Telford, et al.Pageof 44